Janus Henderson Group PLC Aclaris Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

  • $187 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$0.64 - $6.49 $33 - $343
-53 Reduced 0.26%
20,300 $21,000
Q3 2023

Nov 14, 2023
BUY
$6.56 - $10.95 $196 - $328
30 Added 0.15%
20,353 $139,000
Q2 2023

Aug 14, 2023
SELL
$7.89 - $10.64 $520 - $702
-66 Reduced 0.32%
20,323 $210,000
Q1 2023

May 15, 2023
BUY
$7.07 - $17.95 $144,150 - $365,982
20,389 New
20,389 $164,000

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $195M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email